| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17b7199c07621c45e918d5a407832f15 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 |
| filingDate |
2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cc9fbb9cb1008bc66ae6e661d4b12ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf7fb40179dd6831516c018de87abb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_605fa737d7ef7a56c98b44548fd05d47 |
| publicationDate |
2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105431145-A |
| titleOfInvention |
Pharmaceutical formulations for subcutaneous administration of furosemide |
| abstract |
The present teachings relate to a liquid pharmaceutical formulation of furosemide, wherein the pharmaceutical formulation comprises a molar excess of tris(hydroxymethyl)aminomethane to furosemide, has a pH of 7 to 8.5, and greater than or equal to about 50 mM tris( hydroxymethyl) aminomethane concentration. The present teachings can improve the stability of liquid pharmaceutical formulations comprising furosemide and the suitability of such pharmaceutical formulations for subcutaneous administration or delivery. |
| priorityDate |
2013-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |